To Invest or Not: Valeo Pharma (VPH.C)

Reza Golzadeh
November 11, 2021

In this episode, we revisit Valeo Pharma (VPH.C) to get an update on their product portfolio, stock price, and financials. Is VPH.C a good long term investment? Tune In!

Golzadeh, Pharmaceuticals, Today's Analysis, Video

Valeo Pharma (VPH.C) gets their Hesperco flavonoid medicine on shelves with Loblaws brand

Equity.Guru

Investment information for the new generation

To Invest or Not: Valeo Pharma (VPH.C)

Related Posts

Valeo Pharma (VPH.C) gets their Hesperco flavonoid medicine on shelves with Loblaws brand

Valeo Pharma Inc. (VPH.C) Enters PLA with Quebec Minister of Health

Today’s Idea: Valeo Pharma (VPH.C) Boasts an Impressive Portfolio and Achieves Significant Growth

Chart Attack: Valeo Pharma (VPH.C) Finds Buyers and Holds the Uptrend

Valeo Pharma (VPH.C) – Investor Roundtable #3

Analysis: Valeo Pharma (VPH.C) down 34% YTD, sales over the last 12 months at $12 million

Leave a Reply Cancel reply

Discover

Learn More

Contact

Follow Us